NIH-funded research NIH-funded research

Investigating how obesity affects protein quality control in endometrial cancer

Official title: Does obesity influence protein quality control in endometrial cancer?

Funded at Wayne State University · NIH-10980557 · Data updated 2026-11-12

This study is looking at how being overweight might affect the way cancer cells in the uterus work, especially in women with endometrial cancer, to help find better ways to prevent and treat this type of cancer.

More Obesity research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startApril 1, 2021
Project endNovember 30, 2025
Funding year2025
Award (this year)$249,000
NIH project number5R00CA252152-05
Project IDNIH-10980557 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women who are obese and at risk for developing endometrial cancer.

Less likely to help

Patients who are not obese or do not have a risk of endometrial cancer may not benefit from this research.

What this research studies

This research explores the relationship between obesity and endometrial cancer (EC), focusing on how excess body weight may influence the effectiveness of protein quality control mechanisms in cancer cells. The study aims to understand the role of genetic mutations, particularly in the PI3K pathway, in the context of obesity and its impact on cancer development. By examining how obesity-induced stress affects cell survival and death in the uterus, the research seeks to uncover critical insights that could lead to better prevention and treatment strategies for EC in obese women.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for endometrial cancer in women with obesity.

How similar studies have gone: Other research has indicated that understanding the interplay between obesity and cancer pathways can lead to significant advancements in cancer treatment, suggesting that this approach has potential for success.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Wilson, Michael R — Wayne State University
  • Study coordinator: Wilson, Michael R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.